Trial · NCT02302339
Results by group50
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 50
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Objective Response Rate (ORR) | Glembatumumab Vedotin | 7 | Participants | ||
| Objective Response Rate (ORR) | Glembatumumab Vedotin and Varlilumab | 1 | Participants | ||
| Objective Response Rate (ORR) | Glembatumumab Vedotin and PD-1 Targeted Checkpoint Inhibitor | 4 | Participants | ||
| Objective Response Rate (ORR) | Glembatumumab Vedotin and CDX-301 | 0 | Participants | ||
| Adverse Events of the Combination of Glembatumumab Vedotin and CDX-301 (in Cohort 4). | Glembatumumab Vedotin and CDX-301 | Leukopenia | 1 | Participants | |
| Adverse Events of the Combination of Glembatumumab Vedotin and CDX-301 (in Cohort 4). | Glembatumumab Vedotin and CDX-301 | Abdominal pain | 1 | Participants | |
| Adverse Events of the Combination of Glembatumumab Vedotin and CDX-301 (in Cohort 4). | Glembatumumab Vedotin and CDX-301 | Constipation | 2 | Participants | |
| Adverse Events of the Combination of Glembatumumab Vedotin and CDX-301 (in Cohort 4). | Glembatumumab Vedotin and CDX-301 | Dyspepsia | 2 | Participants | |
| Adverse Events of the Combination of Glembatumumab Vedotin and CDX-301 (in Cohort 4). | Glembatumumab Vedotin and CDX-301 | Nausea | 1 | Participants | |
| Adverse Events of the Combination of Glembatumumab Vedotin and CDX-301 (in Cohort 4). | Glembatumumab Vedotin and CDX-301 | Stomatitis | 1 | Participants | |
| Adverse Events of the Combination of Glembatumumab Vedotin and CDX-301 (in Cohort 4). | Glembatumumab Vedotin and CDX-301 | Vomiting | 1 | Participants | |
| Adverse Events of the Combination of Glembatumumab Vedotin and CDX-301 (in Cohort 4). | Glembatumumab Vedotin and CDX-301 | Fatigue | 3 | Participants | |
| Adverse Events of the Combination of Glembatumumab Vedotin and CDX-301 (in Cohort 4). | Glembatumumab Vedotin and CDX-301 | Hepatic pain | 1 | Participants | |
| Adverse Events of the Combination of Glembatumumab Vedotin and CDX-301 (in Cohort 4). | Glembatumumab Vedotin and CDX-301 | Mucosal infection | 1 | Participants | |
| Adverse Events of the Combination of Glembatumumab Vedotin and CDX-301 (in Cohort 4). | Glembatumumab Vedotin and CDX-301 | Urinary tract infection | 1 | Participants | |
| Adverse Events of the Combination of Glembatumumab Vedotin and CDX-301 (in Cohort 4). | Glembatumumab Vedotin and CDX-301 | Alanine aminotransferase increased | 2 | Participants | |
| Adverse Events of the Combination of Glembatumumab Vedotin and CDX-301 (in Cohort 4). | Glembatumumab Vedotin and CDX-301 | Aspartate aminotransferase increased | 3 | Participants | |
| Adverse Events of the Combination of Glembatumumab Vedotin and CDX-301 (in Cohort 4). | Glembatumumab Vedotin and CDX-301 | Blood alkaline phosphatase increased | 1 | Participants | |
| Adverse Events of the Combination of Glembatumumab Vedotin and CDX-301 (in Cohort 4). | Glembatumumab Vedotin and CDX-301 | Neutrophil count decreased | 1 | Participants | |
| Adverse Events of the Combination of Glembatumumab Vedotin and CDX-301 (in Cohort 4). | Glembatumumab Vedotin and CDX-301 | Platelet count decreased | 1 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02302339/results